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Abstract
Xipamide (1), a photosensitive diuretic drug is photolabile under anaerobic conditions and with UVA light. In the present study
the photochemical behavior of xipamide was investigated in the presence of both electron donor and acceptor. When xipamide
(1) was irradiated with a high-pressure mercury lamp under anaerobic conditions in the presence of electron-donor N,N-dimethyl
aniline (DMA) it afforded photoproduct 2  and in the presence of an electron-acceptor 1,4-dicyanonaphthalene (DCN) it afforded
photoproduct 3. The product formation was explained through the photoinduced electron transfer mechanism. Products were isolated
and identified on the basis of IR, NMR and mass spectral studies.
© 2013 Taibah University. Production and hosting by Elsevier B.V. All rights reserved.
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Drug photochemistry has been the object of a con-
siderable amount of attention, especially in the last
decade. Such interest has been promoted by the fact
that even though many of these compounds are excel-
lent therapeutical agents, they are also known to often
cause phototoxic and/or photoallergic phenomena [1–3].
Phototoxic disorders have a high incidence, whereas
photoallergic reactions are much less frequent in human∗ Corresponding author. Tel.: +91 9058970731.
E-mail addresses: remiya59@rediffmail.com,
anamikagupta0@lycos.com (A. Gupta).
Peer review under responsibility of Taibah University
Production and hosting by ElsevierELSEVIER
1658-3655 © 2013 Taibah University. Production and hosting by
Elsevier B.V. All rights reserved.
http://dx.doi.org/10.1016/j.jtusci.2013.11.002population. Detailed understanding of the molecular
mechanism of photosensitization by drug is essential to
anticipate and prevent the appearance of phototoxic or
photoallergic side-effect. Many photosensitization reac-
tions may be explained on the basis of the mechanism
Type I (radical mediated) or Type II (singlet oxygen
mediated). There are photosensitizing drugs of varied
structural variety and significant variations in the pho-
totoxic mechanisms must be expected depending on the
difference in structural features [4]. It is therefore highly
significant to study photochemical reaction of each indi-
vidual phototoxic drug.
Diuretics are among the most widely used clinical
agents and their discovery was a great success of both
synthetic organic chemistry and pharmacology [5], with
most of these agents being discovered in the late 50s
and 60s. Right from the beginning of research in this
field, it was clear that many compounds incorporating
SO2NH2 groups showed great pharmacological activ-
ity [6]. Diuretic agents are drugs that increase the renal
excretion of water and solutes (mainly sodium salts). The
main purposes of diuretic therapy are to decrease fluid
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olume of the body and to adjust the water and elec-
rolyte balance [7]. Diuretics are drugs broadly used in
linical practice mainly in the treatment of hypertension
nd in different kinds of edema [8]. Diuretics may be
lassified according to their chemical structure, mech-
nism, primary site of action in the nephron and their
iuretic potency in thaiazide and non thiazide [9]. Non
hiazide diuretic drugs are widely used as antihyperten-
ive agents in clinical treatment [10], but these drugs are
lso well known to exhibit phototoxic, photomutagenic
nd photocarcinogenic properties, often causing unde-
irable side effects when patients are exposed to light,
specially at UV-A wavelengths [11].
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Xipamide (4-chloro-5-sulfamylsalicyloyl-2′,6′-
dimethylamilide) is a potent non-thiazide diuretic with
a greater natriuretic effect than the thiazides and a
less abrupt onset and longer duration of action than
furosemide [12,13]. It is an effective antihypertensive
drug, appears to be a more effective diuretic than the
thiazides and may cause a lower potassium loss relative
to sodium excretion than these drugs [14,15]. Xipamide
offers a suitable alternative to other diuretics in the
treatment of patients with mild to moderate hypertension
and of patients with oedema due to a variety of causes
[16,17]. It belongs to the group of diuretics, which
have been considered as doping substances since 1986
products of xipamide.
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[18]. In recent years, diuretics have been abused in
sport to reduce body weight in order to qualify for a
lower weight class and to manipulate urine to avoid a
positive result in doping tests [19]. The most frequently
reported side effects of xipamide include mild upper
gastrointestinal symptoms, anorexia or nausea, and
tiredness and fatigue [20]. Dizziness (often postural)
and vertigo have also occurred infrequently and were
probably related to the extent of reduction in blood pres-
sure. Xipamide, like the thiazide and ‘loop’ diuretics,
causes net potassium loss, but this has varied according
to the country of investigation [21]. There have been
occasional reports of considerable decreases in serum
potassium to concentrations as low as 2.2 mmol/L and of
symptomatic hypokalaemia [22]. As might be expected,
xipamide has caused small increases in average blood
urea and serum urate concentrations in some studies,
and occasional increases in blood glucose and of plasma
lipids in diabetic patients [23]. Despite their excellent
therapeutic activity xipamide induces phototoxicity
as a significant side effect [24,25]. In general the
mechanisms underlying the phototoxic reactions of
xipamide are not known, and one prerequisite for a
deeper understanding is the exact knowledge of the
photochemistry of this drug. herein we present an
overview of the photochemical properties of xipamide.
Evidence about the fragmentation modes and the inter-
mediates occurring is discussed. A rationalization of the
photoreactivity of the drug molecules is an important
step in the understanding of the photodegradative
paths occurring in biological environments and in
the correlation between structural characteristics and
phototoxicity. In the present study we have elucidate
the photobehavior of the photosensitive diuretic drug
xipamide under anaerobic conditions in presence of both
electron donor and acceptor in UV-A light. Photolysis
of xipamide (1) resulted in the formation of two major
photodegradation products, identified as 2  and 3  from
their spectral (IR, 1H NMR, 13C NMR, mass spectra)
properties (Scheme 1). Photoproducts are presumably
produced by photoinduced intermolecular electron
transfer mechanism.
2.  Experimental
2.1.  Chemicals
All chemicals used were of analytical grade. Pure
xipamide was obtained from Taj Pharmaceuticals Ltd.,
India. N,N-dimethylaniline and 1,4-dicyanonaphthalene
was purchased from Sigma Aldrich (India). Photo-
chemical reactions were carried out in quartz fittedrsity for Science 8 (2014) 64–70
immersion well photochemical reactor equipped with
400 W medium pressure mercury vapor lamp with con-
tinuous supply of water. UV spectra were recorded on a
Shimadzu 160 A Instrument. IR spectra were recorded
in KBr discs on a Perkin Elmer model spectrum RXI. 1H
NMR and 13C NMR spectra were recorded on a Bruker
Avance-DRX-300 Spectrometer using SiMe4 as inter-
nal standard and CD3OD as solvent. High resolution
mass spectra were determined with a VG-ZAB-BEQ9
spectrometer at 70 eV ionization voltage. Column Chro-
matography was performed on silica gel 60 (70–230
mesh); TLC was carried on Merck silica gel 60 F254
(0.2 mm thick plates).
2.2.  General  photoirradiation  procedure
A solution of xipamide in methanol was stirred for
1 h before irradiation and was kept bubbling during the
irradiations. The course of reaction was monitored by
thin layer chromatography on pre-coated silica gel TLC
plates using chloroform–acetone (9:1) mixture. After the
completion of reaction (when desired conversions have
reached) the solvent was removed in a rotary evapo-
rator and products were purified by silica gel column
chromatography.
2.3.  Irradiation  of  xipamide  in  presence  of  electron
donor
Methanolic solution of xipamide (XIP, 1) (295,
0.8 mM) in presence of electron donor, N,N-
dimethylaniline (DMA) [26] was irradiated for 5 h
at 254 nm. After following the steps described in
general photoirradiation procedure, 2-choloro-5-((2, 6-
dimethylphenyl)carbamoyl)-4-hydroxybenzenesulfonic
acid (2) was obtained as a major photoproduct.
2.4.  2-Choloro-5-((2,
6-dimethylphenyl)carbamoyl)-4-
hydroxybenzenesulfonic  acid
(2)
Yield: 105 mg (35.59%); HRMS calcd. For (M+)
C15H14ClNO5S 355.7934 Found 355.7930; IR (KBr)
3592, 3294, 3100, 1715, 1601, 1355, 1345 cm−1; 1H
NMR (CD3OD, δ, ppm): 8.36 (s, 1H, H-6), 8.0 (s, 1H,
NH), 7.19 (s, 1H, H-3), 6.83 (d, 2H, H-3 and H-5 of
phenyl), 6.74 (m, 1H, H-4 of phenyl), 4.9 (s, 1H, OH),
2.34 (d, 6H, 2CH3 of phenyl), 2.0 (s,1H, SO3H); 13C
NMR (CD3OD, δ, ppm): 163.9, 136.9, 136.6, 134.5,
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33.9, 126.2, 124.1, 119.1, 118.0, 15.3; MS: m/z: 355
M+), 338 (M+-17), 320 (M+-35).
.5.  Irradiation  of  xipamide  in  presence  of  electron
cceptor
Methanolic solution of xipamide (XIP, 1) (295,
.8 mM) in presence of electron acceptor, 1,4-
icyanonaphthalene (DCN) [27], was irradiated for
 h at 254 nm. After following the steps described in
eneral photoirradiation procedure, 4-hydroxy-N-(2,6-
imethylphenyl)-2-hydroxy-5-sulfamoylbenzamide (3)
as obtained as a major photoproduct.
.6.  4-Hydroxy-N-(2,6-dimethylphenyl)-2-hydroxy-
-sulfamoylbenzamide
3)
Yield: 110 mg (37.2%) HRMS calcd. For (M+)
15H16N2O5S 336.3629 Found 336.3625; IR (KBr):
Scheme 2. Mechanistic pathway of thersity for Science 8 (2014) 64–70 67
3592, 3310, 3294, 3100, 1715, 1601, 1345 cm−1; 1H
NMR (CD3OD, δ, ppm): 8.26 (s, 1H, H-6), 8.0 (s, 1H,
NH), 6.84 (d, 2H, H-3 and H-5 of phenyl), 6.74 (m, 1H,
H-4 of phenyl), 6.64 (s, 1H, H-3), 4.98 (s, 2OH), 2.35
(d, 6H, 2CH3), 2.0 (s, 2H, NH2); 13C NMR (CD3OD, δ,
ppm): 164.5, 163.9, 156.8, 134.4, 134.1, 126.2, 124.1,
123.1, 114.0, 112.5, 103.9, 15.3; MS: m/z: 336 (M+), 319
(M+-17).
3.  Results  and  discussion
When methanolic solution of xipamide (XIP) was
irradiated with medium pressure mercury vapor lamp
in an immersion well type photo reactor in presence of
DMA, 2-choloro-5-((2,6-dimethylphenyl)carbamoyl)-
4-hydroxybenzenesulfonic acid (2) was obtained as a
major photoproduct. When irradiation was carried out in
presence of DCN, 4-hydroxy-N-(2,6-dimethylphenyl)-
2-hydroxy-5-sulfamoylbenzamide (3) was obtained as
a major photoproduct (Scheme 1). The photoproducts
 formation of photoproduct 2.
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were isolated and identified from their spectral (IR, 1H
NMR, 13C NMR, and mass spectra) properties. The
assigned structures to these products well correspond to
their observed spectral properties. The assigned struc-
tures to these products well correspond to their observed
spectral properties. All the products obtained by photo-
irradiation of xipamide (XIP), were characterized on the
basis of the following spectral evidences. The 1H NMR
and 13C NMR spectrum of compound 2 were similar to
those of 1 except for signals obtained due to the conver-
sion of sulfonamide to sulfonic acid. The 1H NMR signal
at δ  2.0 was a singlet for one proton clearly indicated that
only sulfonamide group is changed to sulfonic acid. This
was also supported by 13C NMR and mass spectroscopy.
13C NMR values corresponding to C-2, C-3, C-4, C-5,
and C-6 were only slightly affected. 13C NMR signal at
136.6 indicated the change of sulfonamide to sulfonic
acid this was confirmed by the presence of IR band at
1355 cm−1 (S O, str.), slightly increases in frequency
due to more electronegative oxygen atom.Spectroscopic analysis of 3  were identified by IR, 1H
NMR and 13C NMR and mass spectra. The IR spec-
trum showed absorption bands at 1345 cm−1 (S O, str),
Scheme 3. Mechanistic pathway of thersity for Science 8 (2014) 64–70
and more characteristic band at 1089 (C Cl Ar.str) are
missing from XIP. That’s only the sulfonamide ring were
affected and also identified by 1H NMR, the signals at
δ 4.98 broad, singlet peak gives two phenolic hydroxyl
groups were present in aromatic ring and other two aro-
matic benzene protons in the same ring were shielding
at δ  6.64 (s, H-3), and 8.26 (s, H-6) due to introduced of
hydroxyl group in the ring. This evidence fully sported
by 13C NMR, the signals at 164.5 for C-2 was highly
deshielded and other C-1, C-3, C-5, C-6 also highly
affected due to hydroxyl group in the ring, other car-
bonyl and second aromatic ring were unaffected that
clearly indicated the two hydroxyl groups are present
in one aromatic ring. On the basis of IR, 1H NMR, 13C
NMR and mass spectra suggested the chlorine atom was
replaced by hydroxyl group.
The formation of photoproducts has been rationalized
through photoinduced intermolecular electron transfer
mechanism as given in Schemes 2 and 3.
When xipamide (XIP) was irradiated in presence
electron donor N,N-dimethyl aniline (DMA), XIP
reaches in excited state and in excited state it accept
an electron from DMA to form XIP radical anion
 formation of photoproduct 3.
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nd DMA radical cation and in subsequent step XIP
adical anion on hydrolysis yield photoproduct 2 by
oosing ammonia (Scheme 2) similarly when the
IP was irradiated in presence of electron acceptor
,4-dicyanonaphthalene (DCN), XIP reaches in excited
tate and in excited state XIP donate an electron to DCN
nd form XIP radical cation and DCN radical anion and
n next step XIP radical cation on hydrolysis yield pho-
oproduct 3 by the substitution of chlorine by hydroxyl
roup and by back electron transfer (Scheme 3).
o conclude, the present results have shown that in
resence of both electron acceptor and donor, drug
ndergoes photodegradation to yield 2-choloro-5-((2, 6-
imethylphenyl)carbamoyl)-4-hydroxybenzenesulfonic
nd 4-hydroxy-N-(2,6-dimethylphenyl)-2-hydroxy-
-sulfamoylbenzamide as main photodegradation
roducts through photoinduced intermolecular electron
ransfer mechanism and from the above study it is clearly
ndicated that during the fragmentation of xipamide in
resence of both electron donor and acceptor radical
ons are generated and it is a well known fact that
adical ion is responsible for phototoxicity [28,29].
o the phototoxicity of xipamide may possible due to
hese radical ions; hence the present study may find
ts significance in rationalizing the phototoxicity of
he xipamide. Therefore, the obtained data confirmed
hat adequate light protection should be adopted for
he handling and storage of xipamide and suggest that
xcessive sunlight should be avoided after the drug
onsumption.
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